4/A//SEC Filing
Violin Jonathan 4/A
Accession 0000899243-23-004233
CIK 0001590750other
Filed
Feb 6, 7:00 PM ET
Accepted
Feb 7, 6:35 PM ET
Size
9.9 KB
Accession
0000899243-23-004233
Insider Transaction Report
Form 4/AAmended
Violin Jonathan
President and COO
Transactions
- Exercise/Conversion
Common Stock
2023-02-02$0.15/sh+50,000$7,500→ 530,905 total - Exercise/Conversion
Stock Option (Right to Buy)
2023-02-02−50,000→ 239,205 totalExercise: $0.15Exp: 2030-09-23→ Common Stock (50,000 underlying) - Sale
Common Stock
2023-02-02$36.80/sh−50,000$1,840,000→ 480,905 total
Footnotes (3)
- [F1]Due to a broker error, the Form 4 filed by the Reporting Person on February 3, 2023 incorrectly reported the source of shares sold on February 2, 2023 pursuant to the Reporting Person's Rule 10b5-1 trading plan. This amendment reflects the exercise of stock options for 50,000 shares of common stock, which were the source of the shares sold.
- [F2]This transaction was executed pursuant to a Rule 10b5-1 trading plan in multiple trades at prices ranging from $36.1523 to $37.3689. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F3]The option vested 25% on September 23, 2021 and then in equal monthly installments over the following 3 years, subject to the Reporting Person's continued service to Issuer through each vesting date.
Documents
Issuer
Viridian Therapeutics, Inc.\DE
CIK 0001590750
Entity typeother
Related Parties
1- filerCIK 0001730615
Filing Metadata
- Form type
- 4/A
- Filed
- Feb 6, 7:00 PM ET
- Accepted
- Feb 7, 6:35 PM ET
- Size
- 9.9 KB